IPX#

Related by string. * * *

Related by context. All words. (Click for frequent words.) 67 pramipexole 66 carbidopa levodopa 66 Traficet EN 65 teriflunomide 65 CIMZIA TM 64 SNT MC# 64 rotigotine 64 levetiracetam 64 6R BH4 64 MIRAPEX ER 64 Gabapentin GR 63 Amrubicin 63 ularitide 63 MAP# 63 RhuDex ® 63 NUVIGIL 63 tanespimycin 63 KNS # 63 Cleviprex TM clevidipine 63 GAMMAGARD 63 IR prednisone 63 levodopa carbidopa 63 Phenoptin 63 Requip XL 62 diabetic neuropathic pain 62 interferon beta therapy 62 tezampanel 62 zileuton 62 INCB# [002] 62 ropinirole 62 lacosamide 62 palonosetron 62 ProSavin 62 RAPTIVA 62 Zelrix 62 Laquinimod 62 AGILECT R 62 Tasimelteon 62 apremilast 62 active comparator 62 phase IIb clinical 62 INCB# [001] 62 Alzhemed TM 62 RRMS patients 62 immunomodulatory therapy 62 tasimelteon 62 AGILECT ® 62 Perforomist TM Inhalation Solution 62 alvimopan 62 safinamide 61 lurasidone 61 USL# 61 PF # [001] 61 ancrod 61 albiglutide 61 desvenlafaxine succinate 61 sufentanil 61 Archexin 61 adalimumab Humira 61 brivaracetam 61 AZILECT R 61 Pimavanserin 61 Ventavis 61 hour bronchodilation 61 R#/MEM # 61 oxymorphone ER 61 Dual Opioid 61 golimumab 61 fluticasone furoate 61 MIRAPEX 61 phase IIb trial 61 opioid induced constipation 61 dirucotide 61 TELINTRA 61 rilonacept 61 ORENCIA ® 61 Phase Ib study 61 subcutaneous formulation 61 rasagiline tablets 61 PROMACTA 61 PRT# 61 mometasone furoate 61 PDE4 inhibitor 61 novel oral anticoagulant 61 baminercept 61 relapsed multiple myeloma 61 TELCYTA 61 Natalizumab 61 riociguat 61 ABILIFY ® 61 rasagiline 60 LUNESTA 60 Relivar 60 RhuDex 60 elotuzumab 60 lubiprostone 60 Bezielle 60 Troxatyl 60 TBC# 60 COPAXONE R 60 ALGRX 60 APEX PD 60 Phase 2a trial 60 MoxDuo IR 60 tapentadol ER 60 EXPAREL TM 60 cangrelor 60 Rebif ® 60 EOquin TM 60 OMNARIS Nasal Spray 60 ACTEMRA TM 60 Tolvaptan 60 Gattex 60 Pramipexole 60 GSK# [001] 60 Focalin XR 60 Ambrisentan 60 CIMZIA ™ 60 forodesine 60 phase IIa clinical 60 opioid induced bowel dysfunction 60 YONDELIS 60 oral rivaroxaban 60 Neupro R 60 DDP# 60 tolerability 60 abiraterone acetate 60 Rotigotine 60 Cladribine Tablets 60 refractory gout 60 inhaled iloprost 60 registrational 60 Firazyr 60 methylnaltrexone 60 Phase #b/#a trial 60 vidofludimus 60 opioid induced constipation OIC 60 RSD# 60 Oral NKTR 60 Raptiva ® 60 oral prodrug 60 PHX# 60 Asentar 60 TEMODAL 60 ulimorelin 60 beta 1a 60 LAF# 60 Dabigatran etexilate 60 oral anticoagulant 60 oral methylnaltrexone 60 ruxolitinib 60 Virulizin ® 60 Mipomersen 60 alemtuzumab Campath 60 Iluvien ® 60 Remicade infliximab 60 oral salmon calcitonin 59 IFN beta 59 pitavastatin 59 Q#IR 59 nucleoside analog 59 placebo controlled clinical 59 Phase IIa clinical 59 eszopiclone 59 ILUVIEN ® 59 dopamine partial agonist 59 formoterol fumarate 59 MoxDuo 59 ciclesonide 59 efalizumab 59 biologic therapy 59 long acting muscarinic 59 Xanafide 59 torezolid phosphate 59 Tamibarotene 59 Neurodex 59 OMS# 59 Plicera 59 divalproex sodium 59 DP b# 59 Rasagiline 59 Dacogen injection 59 Lialda 59 PD LID 59 levodopa therapy 59 tasocitinib 59 pioglitazone HCl 59 eltrombopag 59 Tarceva erlotinib 59 histone deacetylase HDAC inhibitor 59 Onbrez Breezhaler 59 calcineurin inhibitor 59 MACUGEN 59 generation purine nucleoside 59 FROVA 59 nebulized formoterol fumarate 59 visilizumab 59 somatostatin analog 59 phase Ib 59 Aryplase 59 monotherapy 59 TRO# 59 Synavive 59 BrachySil TM 59 telcagepant 59 Frova ® 59 ELND# 59 amrubicin 59 Fibrillex TM 59 relapsed MM 59 IMA# 59 dose escalation trial 59 VELCADE melphalan 59 Inhalation Solution 59 KRN# 59 Cloretazine R VNP#M 59 Phase III confirmatory 59 Aflibercept 59 Betaferon R 59 LIALDA 59 miconazole Lauriad ® 59 Perforomist ™ Inhalation Solution 59 relapsing multiple sclerosis 59 Diabetic Macular Edema DME 59 Stalevo 59 REMICADE ® 59 COPAXONE ® 59 tipranavir r 59 AZILECT 59 KAPVAY ™ 59 pharmacokinetic PK study 59 IV bolus 59 CCX# B 59 FIRMAGON 59 double blinded placebo 59 tocilizumab 59 ACTEMRA 59 etanercept 59 metformin HCl 59 DermaVir Patch 59 REMINYL ® 59 aclidinium 59 NVA# 59 vascular disrupting agent 59 BAY #-# 59 Cimzia ® certolizumab pegol 59 Betaferon ® 59 TNF alpha inhibitor 59 HuMax CD4 59 azilsartan medoxomil 59 ® natalizumab 59 HQK 59 subcutaneously administered 59 oral FTY# 59 Lodotra 59 Evoltra ® 59 eosinophilic asthma 58 CIMZIA TM certolizumab pegol 58 teduglutide 58 SYN# 58 sorafenib tablets 58 mGluR5 NAM 58 CTAP# Capsules 58 Safinamide 58 RoACTEMRA 58 aripiprazole 58 PEG PAL 58 LATUDA 58 AZILECT ® 58 Zenvia ™ 58 cannabinor 58 Aptivus ® 58 INVEGA SUSTENNA 58 bicifadine 58 dose escalation Phase 58 Vimpat R 58 thalidomide Thalomid 58 glatiramer acetate 58 recurrent GBM 58 NLX P# 58 atrasentan 58 phase 2a 58 Aloxi injection 58 Proquin XR 58 octreotide 58 inhaled treprostinil 58 Phase 2b study 58 ThermoDox ® 58 Cimzia TM 58 entacapone 58 phase IIb 58 ambrisentan 58 PEG INTRON 58 QVA# 58 blinatumomab 58 Eltrombopag 58 pomalidomide 58 Zerenex 58 rapid virologic response 58 Azedra 58 TG# [003] 58 etanercept Enbrel 58 Sinemet 58 SIMPONI 58 Certolizumab pegol 58 Targretin 58 Solzira 58 Tarceva TM 58 Rezular 58 mapatumumab 58 QLT# 58 RLY# 58 edoxaban 58 denileukin diftitox 58 oxypurinol 58 ADVANCE PD 58 metastatic carcinoid 58 placebo controlled Phase 58 Vimpat ® 58 CYCLOSET 58 Phase IIa trial 58 Tezampanel 58 ALVESCO HFA 58 Phase 2a clinical 58 zileuton CR 58 Pirfenidone 58 salmeterol fluticasone 58 dirucotide MBP# 58 cediranib 58 IIa trial 58 RhuDex TM 58 mertansine 58 Interferon alpha 58 ICA # 58 Lacosamide 58 trabectedin 58 lumiliximab 58 Phase 2b clinical 58 PS# [001] 58 constipation OIC 58 refractory acute myeloid 58 Dasatinib 58 VAPRISOL 58 perampanel 58 INVEGA ® 58 DU #b 58 Durezol 58 Dalbavancin 58 HGS# 58 iniparib 58 acting muscarinic antagonist 58 adenosine injection 58 aclidinium bromide 58 Cycloset 58 Phase III clinical 58 metastatic hormone refractory 58 Zemplar 58 Androxal TM 58 OvaRex R 58 AQ4N 58 tolterodine 58 aplindore 58 Phase Ib clinical 58 pan HDAC inhibitor 58 nalbuphine ER 58 Panzem R 58 BRIM2 58 Phase IIa 58 OMNARIS HFA 58 atacicept 58 relapsing forms 58 Ventavis ® 58 CDP# 58 Phase 1a clinical 58 CRLX# 58 Golimumab 58 protease inhibitor PI 58 registrational trial 58 Raptiva R 58 alvespimycin 58 Phase IIb clinical 58 Asmanex 58 vernakalant 58 phase IIa 58 clinically meaningful reductions 58 metaglidasen 58 Alocrest 58 lomitapide 58 romidepsin 58 ZOLINZA 58 refractory metastatic colorectal cancer 58 Cimzia ® 58 PEG SN# 58 posaconazole 58 dexpramipexole 58 fistulizing Crohn disease 58 leukotriene receptor antagonist 58 Dyloject TM 58 irbesartan 57 Relovair 57 Keppra XR 57 Bronchitol 57 JANUVIA 57 8mg/kg 57 fosbretabulin 57 Milnacipran 57 KAPIDEX 57 calcineurin inhibitors 57 PROSTVAC TM 57 Interferon beta 1a 57 dacarbazine 57 bronchodilation 57 relapsed refractory multiple myeloma 57 targeted radiotherapeutic 57 BROVANA 57 Perforomist Inhalation Solution 57 Evoltra 57 TRANSDUR Sufentanil 57 Campath alemtuzumab 57 dosing intervals 57 GALNS 57 sorafenib Nexavar 57 photodynamic therapy PDT 57 briakinumab 57 symptomatic neurogenic orthostatic hypotension 57 MBP# [001] 57 romiplostim 57 SCH # 57 iloperidone 57 Genz # 57 Fludara 57 oral renin inhibitor 57 MAGE A3 ASCI 57 NP2 Enkephalin 57 Telbivudine 57 levodopa induced dyskinesia 57 Alvesco R 57 recurrent NSCLC 57 Phase IIIb clinical 57 ritonavir boosted 57 obatoclax 57 Chemophase 57 PEG Intron 57 Zybrestat 57 Dapagliflozin 57 rFIXFc 57 Kepivance 57 Arcalyst 57 AGGRASTAT ® 57 mGluR5 negative 57 metoprolol succinate 57 Adalimumab 57 afamelanotide 57 ganetespib 57 CCX# 57 Lamictal XR 57 velafermin 57 liposomal formulation 57 bosentan 57 ACZ# 57 Phase 2b clinical trials 57 inhaled AAT 57 Azilect ® 57 Locteron 57 PXD# 57 FAMPYRA 57 VPRIV 57 RezularTM 57 Rebif R 57 tacrolimus ointment 57 SILENOR TM 57 RLAI 57 Cloretazine 57 ENTEREG ® 57 otelixizumab 57 Locteron ® 57 Serada 57 MIRCERA 57 placebo controlled Phase III 57 leukemia AML 57 pharmacokinetic profile 57 dimebon 57 BEMA Buprenorphine 57 custirsen 57 IFN α 57 fluticasone salmeterol 57 lenalidomide dexamethasone 57 asenapine 57 beta2 agonist 57 certolizumab 57 tafamidis 57 intravenous dosing 57 mirtazapine 57 sapacitabine 57 PRISTIQ 57 oxybutynin 57 clevidipine 57 DPP4 inhibitor 57 treprostinil 57 SPRYCEL ® 57 intermittent dosing 57 Orencia abatacept 57 Phase #/#a 57 AVINZA 57 telbivudine 57 epoetin beta 57 IRESSA 57 antiplatelet agent 57 Torisel 57 INVEGA 57 Instanyl 57 ARCOXIA 57 FOLFOX6 57 ramelteon 57 #mg doses [002] 57 BCR ABL inhibitor 57 Noxafil 57 Zingo TM 57 erlotinib Tarceva ® 57 LEP ETU 57 BRAF inhibitor 57 Copaxone glatiramer acetate 57 Glumetza TM 57 tenofovir emtricitabine 57 potent CYP#A# inhibitors 57 Ophena TM 57 chronic angina 57 PEGylated interferon beta 1a 57 Mitoxantrone 57 leading oral taxane 57 nitazoxanide 57 maximally tolerated dose 57 THALOMID 57 dasatinib Sprycel ® 57 relapsing remitting multiple sclerosis 57 bendamustine 57 tolerability profiles 57 ThGRF 57 eniluracil 57 aripiprazole Abilify 57 elacytarabine 57 ponatinib 57 SRT# [003] 57 paliperidone ER 57 bosutinib 57 granisetron 57 OncoGel 57 Phase #b/#a 57 tamibarotene 57 oral cladribine 57 headache nasopharyngitis 57 Levetiracetam 57 rufinamide 57 LCP Tacro 57 PNP inhibitor 57 Navelbine ® 57 RSD# oral 57 adult chronic ITP 57 Mycamine 57 PRECiSE 57 MabThera Rituxan 57 randomized controlled Phase 57 Soliris eculizumab 57 relapsing MS 57 certolizumab pegol 57 Nexavar ® 57 laquinimod 57 motesanib 57 cystinosis patients 57 Elagolix 57 MoxDuo TM IR 57 Pafuramidine 57 miglustat 57 Actemra tocilizumab 57 Jevtana 57 pertuzumab 57 ofatumumab 57 reslizumab 57 RG# [001] 57 TORISEL 57 insulin detemir 57 olmesartan 57 IBS C 57 mixed dyslipidemia 57 LCP AtorFen 57 phase IIb study 57 Fx #A 57 dose cohorts 57 Erlotinib 57 FOLOTYN ® 56 ABILIFY R 56 DCCR 56 Panzem 56 Romiplostim 56 tgAAC# 56 dose escalation clinical 56 Itopride 56 subcutaneous SC 56 XYZAL R 56 Neulasta ® 56 docetaxel Taxotere ® 56 Clonicel 56 Cimzia R 56 paliperidone palmitate 56 hyperphenylalaninemia HPA due 56 Sym# 56 Northera 56 MYDICAR 56 Sunovion 56 primary Restless Legs 56 cariprazine 56 TNF inhibitor 56 lansoprazole 56 levodopa 56 midstage clinical 56 AeroLEF TM 56 Plenaxis TM 56 Candesartan 56 mesalamine 56 ONTAK 56 ara C 56 Naproxcinod 56 SYMBICORT 56 dabigatran etexilate 56 Study GL# 56 Quinamed 56 EVIZON 56 colesevelam HCl 56 vandetanib 56 Zomig 56 APTIVUS 56 SCIg 56 Vaprisol 56 LEVADEX ™ 56 Octreolin 56 Pegasys ® 56 Tesetaxel 56 Corlux 56 Phase Ib 56 Aplidin 56 Lubiprostone 56 investigational antiplatelet agent 56 Darusentan 56 AGGRASTAT R 56 oxycodone CR 56 galiximab 56 ATL/TV# 56 novel histone deacetylase 56 APTIVUS r 56 Triolex 56 pharmacokinetic profiles 56 STELARA 56 ARIKACE 56 TPI ASM8 56 gabapentin enacarbil 56 administered subcutaneously 56 mg/m2 cohort 56 ocrelizumab 56 Pegasys peginterferon alfa 2a 56 GW# [003] 56 Factor VIIa 56 virus HCV protease inhibitor 56 EOquin 56 Humira adalimumab 56 infliximab Remicade 56 Omnitarg 56 PROVIGIL 56 fingolimod 56 ACOMPLIA R 56 rNAPc2 56 Hsp# Inhibitor 56 CHOP chemotherapy 56 Phase IIb clinical trials 56 goserelin 56 EndoTAG TM -1 56 SinuNase TM 56 ORENCIA R 56 ABILIFY 56 Vidaza azacitidine 56 Adlea 56 Parkinson disease levodopa induced 56 dopaminergic therapy 56 rhIGF-I/rhIGFBP-3 56 Orapred ODT 56 Icatibant 56 antithrombotic 56 NGX# 56 Bifeprunox 56 interferon therapy 56 Personalized Immunotherapy 56 circadian cytokine modulator 56 paricalcitol 56 ELIQUIS 56 BENICAR 56 RAPAFLO R 56 Combo Stent 56 SILENOR 56 MYDICAR ® 56 dyskinesia PD LID 56 Gleevec Glivec 56 ATACAND 56 Phase 1b clinical 56 #mg dose [001] 56 xanthine oxidase inhibitor 56 plus gemcitabine 56 metastatic CRC 56 Serdolect ® 56 INC# 56 tramiprosate 56 regorafenib 56 Carfilzomib 56 Deferiprone 56 Fludara ® 56 bardoxolone methyl 56 CA4P 56 SEROQUEL 56 MGd 56 Daliresp 56 OncoVEX GM CSF 56 ZYFLO 56 SEROQUEL XR 56 Cimzia certolizumab pegol 56 decitabine 56 CEQ# 56 diabetic gastroparesis 56 tolvaptan 56 Starlix 56 CANCIDAS 56 OvaRex ® MAb 56 tiotropium 56 darusentan 56 tipranavir 56 Actimmune ® 56 liposome injection 56 Cetrorelix 56 fluticasone propionate 56 ixabepilone 56 methylnaltrexone bromide 56 trastuzumab DM1 56 radiation sensitizer 56 TMC# r 56 Phase IIb trials 56 Daclizumab 56 Onrigin 56 sulodexide 56 Aurexis 56 Menerba 56 receptor tyrosine kinase inhibitor 56 IRX 2 56 degarelix 56 AeroLEF 56 Ceflatonin R 56 sunitinib malate 56 ADX# 56 latanoprost 56 biologic DMARD 56 ALN TTR# 56 Reverset 56 PEG IFN 56 orally inhaled migraine 56 painful diabetic neuropathy 56 Zelapar 56 VA# [002] 56 etravirine 56 vicriviroc 56 agomelatine 56 Phase IIb trial 56 alefacept 56 rALLy trial 56 sargramostim 56 Tracleer R 56 Arranon 56 LUCENTIS 56 CYT# 56 SinuNase 56 albinterferon alfa 2b 56 oxaliplatin Eloxatin 56 unresectable stage 56 FASLODEX 56 STELARA ™ 56 lucinactant 56 LymphoStat B 56 ximelagatran 56 Azedra TM 56 acetonide FA 56 ISENTRESS 56 TLK# 56 pseudobulbar affect PBA 56 Pazopanib 56 VNP#M 56 #mg BID [003] 56 Restless Legs Syndrome RLS 56 Azilect 56 PF # [002] 56 CIP TRAMADOL ER 56 nilotinib 56 chlorambucil 56 oral ridaforolimus 56 MNTX 56 Anavex #-# 56 plasma kallikrein inhibitor 56 mg BID 56 confirmatory Phase III 56 CLARITY study 56 AMRIX 56 interferon alfa 56 anticancer compound 55 subcutaneous methylnaltrexone 55 levocetirizine 55 Cethrin 55 axitinib 55 exenatide once 55 timolol 55 Initiated Phase 55 SAPHRIS 55 Tocilizumab 55 Degarelix 55 dexanabinol 55 gemcitabine Gemzar ® 55 selegiline 55 HP Acthar Gel repository 55 Zorbtive TM 55 Betaseron ® 55 adalimumab 55 tezampanel NGX# 55 CoFactor 55 ranolazine 55 TYGACIL 55 Loramyc R 55 pegfilgrastim 55 Zemplar Capsules 55 REMICADE 55 rilpivirine 55 #mg BID [001] 55 Clolar ® 55 Ixempra 55 RoActemra 55 quetiapine 55 phase Ib clinical 55 atypical antipsychotic 55 Vernakalant 55 Remodulin 55 Darunavir 55 ZYBRESTAT 55 allosteric modulator NAM 55 Phase 1b trial 55 efficacy tolerability 55 lixisenatide 55 peginterferon alfa 2a 55 INTEGRILIN 55 Lupuzor 55 phase III isavuconazole 55 SINGULAIR 55 selective androgen receptor modulator 55 Bosentan 55 zolmitriptan 55 Velcade bortezomib 55 NEVO ™ 55 Phase 2a 55 ibandronate 55 INCB# [003] 55 Troxatyl TM 55 GV# [001] 55 pradefovir 55 tesetaxel 55 dosage regimen 55 Bortezomib 55 silodosin 55 MabCampath 55 PSN# [002] 55 Avanafil 55 FOLOTYN 55 budiodarone 55 Atacand 55 dosage regimens 55 atazanavir ritonavir 55 dextromethorphan quinidine 55 zafirlukast 55 Zoraxel 55 gabapentin 55 evaluating tivozanib 55 Hycamtin ® 55 fluvastatin 55 MEK inhibitors 55 Telintra 55 pegylated liposomal doxorubicin 55 anti leukemic 55 ALN VSP Phase 55 crizotinib PF # 55 vinorelbine 55 HCV protease inhibitor 55 PEG Interferon lambda 55 BARACLUDE R 55 interferon beta 1b 55 trandolapril 55 CB2 selective receptor agonist 55 MYLOTARG 55 TRISENOX 55 DASISION 55 carboplatin paclitaxel 55 TREANDA 55 esomeprazole 55 interferon beta 1a 55 dacetuzumab 55 Emselex 55 sJIA 55 proton pump inhibitor PPI 55 subcutaneous dosing 55 vorinostat 55 Tekturna HCT 55 YONDELIS R 55 docetaxel Taxotere R 55 EMSAM 55 SNRI 55 favorable pharmacokinetic profile 55 eculizumab therapy 55 Cloretazine ® 55 refractory AML 55 canakinumab 55 Ceflatonin 55 clofarabine 55 JZP 55 rindopepimut 55 ATL# [001] 55 novel VDA molecule 55 ARIMIDEX 55 angiotensin receptor blocker ARB 55 imatinib Gleevec ® 55 Simulect 55 bifeprunox 55 Privigen 55 aspirin clopidogrel 55 recurrent glioblastoma multiforme 55 AVONEX ® 55 omega interferon 55 Spiegelmer ® 55 Proleukin 55 exenatide 55 mg QD 55 Onalta 55 IMiDs 55 betrixaban 55 Glatiramer Acetate 55 aleglitazar 55 orBec 55 Prosaptide 55 MYCAMINE 55 AMPYRA ™ 55 levosimendan 55 Veramyst 55 Sebivo 55 Frovatriptan 55 GAMMAGARD LIQUID 55 Teriflunomide 55 Meets Primary Endpoint 55 Huntexil 55 mTOR inhibitor 55 melphalan prednisone 55 OncoVEX 55 sitaxsentan 55 Annamycin 55 ZACTIMA 55 CG# [003] 55 PEGINTRON TM 55 pancreatic neuroendocrine tumors 55 Ereska 55 Frova R 55 Aliskiren 55 dose dose escalation 55 Phase IIa trials 55 tivozanib 55 Zavesca R 55 Revlimid lenalidomide 55 XOPENEX Inhalation Solution 55 oxcarbazepine 55 Phase III Pivotal 55 Neupro ® 55 Promacta 55 Tasigna nilotinib 55 DOXIL 55 Gefitinib 55 ULORIC 55 alfa 2a 55 Pertuzumab 55 oral bioavailability 55 ribavirin RBV 55 CBLC# 55 Catena ® 55 PREOS R 55 thymalfasin 55 LY# [002] 55 prodrug stimulant 55 relapsed SCLC 55 azacitidine 55 Fibrin Pad 55 tramiprosate Alzhemed TM 55 Serdaxin 55 oral formulation 55 PROCRIT ®

Back to home page